HK1188558A1 - Use of therapeutically active lipids together with method of producing organ tissue-specific therapeutically active lipids - Google Patents

Use of therapeutically active lipids together with method of producing organ tissue-specific therapeutically active lipids

Info

Publication number
HK1188558A1
HK1188558A1 HK14101049.3A HK14101049A HK1188558A1 HK 1188558 A1 HK1188558 A1 HK 1188558A1 HK 14101049 A HK14101049 A HK 14101049A HK 1188558 A1 HK1188558 A1 HK 1188558A1
Authority
HK
Hong Kong
Prior art keywords
therapeutically active
active lipids
organ tissue
producing organ
specific
Prior art date
Application number
HK14101049.3A
Other languages
English (en)
Chinese (zh)
Inventor
沃爾夫岡．斯特里梅爾
Original Assignee
派特有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 派特有限公司 filed Critical 派特有限公司
Publication of HK1188558A1 publication Critical patent/HK1188558A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/554—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK14101049.3A 2005-09-21 2014-01-30 Use of therapeutically active lipids together with method of producing organ tissue-specific therapeutically active lipids HK1188558A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005045152A DE102005045152A1 (de) 2005-09-21 2005-09-21 Verwendung von therapeutisch wirksamen Lipiden nebst Verfahren zur Herstellung von Organ-/Gewebe-spezifischen therapeutisch wirksamen Lipiden

Publications (1)

Publication Number Publication Date
HK1188558A1 true HK1188558A1 (en) 2014-05-09

Family

ID=37460134

Family Applications (2)

Application Number Title Priority Date Filing Date
HK09101733.1A HK1121689A1 (en) 2005-09-21 2009-02-24 Use of therapeutically active lipids together with method of producing organ/tissue-specific therapeutically active lipids
HK14101049.3A HK1188558A1 (en) 2005-09-21 2014-01-30 Use of therapeutically active lipids together with method of producing organ tissue-specific therapeutically active lipids

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK09101733.1A HK1121689A1 (en) 2005-09-21 2009-02-24 Use of therapeutically active lipids together with method of producing organ/tissue-specific therapeutically active lipids

Country Status (12)

Country Link
US (2) US8883426B2 (xx)
EP (1) EP1926499B9 (xx)
CN (2) CN103432589B (xx)
CY (1) CY1115038T1 (xx)
DE (1) DE102005045152A1 (xx)
DK (1) DK1926499T3 (xx)
ES (1) ES2458304T3 (xx)
HK (2) HK1121689A1 (xx)
PL (1) PL1926499T3 (xx)
PT (1) PT1926499E (xx)
SI (1) SI1926499T1 (xx)
WO (1) WO2007033654A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2923710A1 (en) 2014-03-27 2015-09-30 Universitätsklinikum Heidelberg Bacterial phospholipase inhibitors as modulator of colonic bacterial flora
CN110840901A (zh) * 2019-12-12 2020-02-28 南京大学 溶血磷脂酰乙醇胺18:1在制备缓解、治疗炎症性肠病药物中的应用
CN112305120B (zh) * 2020-10-30 2022-02-08 河北医科大学第二医院 代谢物在动脉粥样硬化性脑梗死中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080422A (en) * 1995-10-11 2000-06-27 Talaria Therapeutics, Inc. Methods of angioplasty and cardiac catheterization
US20050227925A1 (en) * 2004-04-08 2005-10-13 Robbert Benner Compositions capable of reducing elevated blood urea concentration
ES2211184T3 (es) * 1998-08-06 2004-07-01 Wolfgang Stremmel Fosfatidilcolina como medicamento con efecto protector de mucosas.
WO2001051003A2 (en) * 2000-01-10 2001-07-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of disease
US7141552B2 (en) * 2000-01-10 2006-11-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases
DE10249890A1 (de) * 2002-10-25 2004-05-13 Wieland, Heinrich, Prof. Dr. Gallensäurekonjugate und damit gebildete Partikel

Also Published As

Publication number Publication date
HK1121689A1 (en) 2009-04-30
PT1926499E (pt) 2014-04-22
US20080166401A1 (en) 2008-07-10
DK1926499T3 (da) 2014-04-14
ES2458304T3 (es) 2014-04-30
EP1926499B1 (de) 2014-01-22
CN103432589B (zh) 2015-04-29
US20150038472A1 (en) 2015-02-05
EP1926499A1 (de) 2008-06-04
WO2007033654A1 (de) 2007-03-29
PL1926499T3 (pl) 2014-06-30
CY1115038T1 (el) 2016-12-14
US8883426B2 (en) 2014-11-11
EP1926499B9 (de) 2014-04-16
DE102005045152A1 (de) 2007-03-22
CN101287499B (zh) 2013-04-03
CN103432589A (zh) 2013-12-11
CN101287499A (zh) 2008-10-15
SI1926499T1 (sl) 2014-05-30

Similar Documents

Publication Publication Date Title
GB2441489B (en) Stylet apparatuses and methods of manufacture
TWI346826B (en) Bonding structure and method of fabricating the same
GB0718972D0 (en) Compounds and methods of making the compounds
EP1904014A4 (en) WOUND ASSOCIATION AND METHOD FOR ITS MANUFACTURE AND USE
EP1957145A4 (en) MICRONADEL ASSEMBLIES AND APPLICATION METHOD
GB0509845D0 (en) Preparation of therapeutic foam
EP2073888A4 (en) MICRONED NEEDLES AND METHOD FOR PRODUCING MICRONED NEEDLES
IL182940A0 (en) Solid electrolyte and method of producing the same
ZA200803555B (en) Manufacture of esters
EP1967171A4 (en) SKIN PATCHES AND METHOD OF MANUFACTURE THEREOF
PL2091385T3 (pl) Miotły i sposoby wytwarzania mioteł
EP1967265A4 (en) BODY HAVING A BEAT STRUCTURE AND METHOD FOR PRODUCING THE SAME
EP1919477A4 (en) METHOD FOR IMPROVING THE GRID OF GROWTH
EP1870460A4 (en) PROCESS FOR PREPARING PROTEINS WITH TRIPELHELIX STRUCTURE
HK1188558A1 (en) Use of therapeutically active lipids together with method of producing organ tissue-specific therapeutically active lipids
EP1951357A4 (en) MICRONADELANTS AND MANUFACTURING METHOD THEREFOR
EP1899157A4 (en) NANOSCALE STRUCTURES AND MANUFACTURING METHOD THEREFOR
GB2423583B (en) Manufacture of interactive surface
EP1977003A4 (en) DISEASE-RELATED METHODS AND MEDIUM
GB0500700D0 (en) Process for the manufacture of 2-alkyl-3-phenylpropionic acids and alcohols
EP2099437A4 (en) POROUS KERATIN CONSTRUCT AND METHOD OF MANUFACTURING THEREOF
GB0714776D0 (en) Play structure and accessories therefor
ZA200800590B (en) Method of improving wakefulness
IL176713A0 (en) Internal structure of mattress and the method to manufacture it
TWI315902B (en) Method of fabricating interconnecting

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190914